Advances in target therapy in lung cancer
Herein, we have reviewed and analysed recent literature, published in 2013 and early 2014, in the context of pre-existing data. Considered target therapies were tyrosine kinase inhibitors of active epidermal growth factor receptor mutations (e.g. erlotinib, gefinitib and afatinib), anaplastic lympho...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2015-03-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/24/135/23.full.pdf+html |